Dr. Mourad Aribi (Professor, PhD, Dr. Hab.) was born in Algeria, on June 2, 1971.
Passionate by Biological sciences, his first graduate diploma was in Biochemistry (1990-1996) about protein-energy malnutrition (marasmus and kwashiorkor) in Tlemcen university of Algeria. He then succeeded in the national contest of post-graduate studies, where he obtained his 3rd Cycle Thesis (formerly Magistere) in Molecular and Cellular Biology (mostly Immunology), over a period of 4 years.
His Thesis research work focused on the study of immunological markers of autoimmunity of type 1 diabetes.
By 2000, he soon enrolled in PhD research in Immunology where he enquired about the role of HLA DR and interleukin-1β in the pathogenesis of type 1 diabetes. He successfully completed his PhD thesis in 2006 from the University of Sidi Bel-Abbès.
His trainings during his thesis work have been mainly towards to France where he collaborated with Professor Naim Khan, Team Leader of Lipids and Cell Signalling (University of Burgundy). This joint-work led him to highlight the association of IL-1β with the risk of type 1 diabetes development.
In 2008, he submitted his candidacy for the university accreditation with a summary of all his research work and was favourably rewarded the Diploma of Dr. Hab. (Habilitation degree).
After completing additional training in Immunology, he obtained a Diploma in Immunological therapies at Paris Descartes University (Paris V) in 2013.
Finally, in June 2013, Dr. Mourad Aribi was promoted to Full Professor.
In parallel with his research on type 1 diabetes, he investigated the pathogenesis of vascular malformations. To further his research in this area, he has set up a high level research collaboration (Hubert Curien Partnership [PHC Tassili, code 10MDU794] Project) with the Molecular Immunogenetics Laboratory of CNRS UPR 1142 of Montpellier (France), directed by Professor Gérard Lefranc. In the light of his research, he has set forth different problematical questions: the study of inflammatory process, SNPs research at the 9p21 locus and identification of pathogenic new gene(s). In 2015, Dr. Mourad Aribi successfully develops a new collaborative PHC Tassili Project with the team of Dr. Salvatore Spicuglia (Technological Advances for Genomics and Clinics (TAGC), Inserm U1090, Luminy, Marseille, France). In this project, they propose to identify and characterize lncRNAs expressed during T cells development and in LAL-T, basing on both large-scale genomic approaches and molecular biology and targeted cell experiments.
During his work, he actively participated in clinical research areas related to Immunology, especially Infection and Immunology; Homeostasis and lymphoproliferative disorders. Thanks to his interdisciplinary skills, he was able to launch, in 2010, a National Research Laboratory of Applied Molecular Biology and Immunology at the University of Tlemcen, involving four teams of different backgrounds dealing with Clinical and Biological studies. In 2011, he was unanimously nominated as Director of the Laboratory.
Through his career as university lecturer, he tries to balance between a strong educational involvement and an appeal to Scientific Research. He started teaching in 1999 at the former Department of Dental Surgery at the Faculty of Medicine of Tlemcen. Dr. Mourad Aribi has also started his teaching of Immunology when creating the Departments of Biotechnology (in 2000, University of Mostaganem) and Pharmacy (in 2003, University of Tlemcen). At present, he manages all the teachings of Immunology at the Biology Department of Tlemcen University. After several years of professional experience and mobility across multiple Universities in North Algeria (Mostaganem, Sidi-Bel-Abbes, Tlemcen), and France (Montpellier, Paris), he headed the teaching team as the Chair of Immunology Education at the University of Tlemcen.